Neuralstem

$4.65
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$1.05 (-17.80%) Today
-$0.20 (-4.12%) As of 4:06 PM EDT after-hours

Why Robinhood?

You can buy or sell Neuralstem and other stocks, options, ETFs, and crypto commission-free!

About CUR

Neuralstem, Inc. operates as a biopharmaceutical company, which engages in the research, development, and commercialization of central nervous system therapies based on human neuronal stem cells and small molecule compounds. Its pipeline includes NSI-189 small molecule program, NSI-566 stem cell therapy program, and novel and proprietary chemical entity screening platform. Read More The company was founded by I. Richard Garr, Karl Y. Johe, and Merrill Solomon in 1996 and is headquartered in Germantown, MD.

CEO
Employees
6
Headquarters
Germantown, Maryland
Founded
1996
Market Cap
5.37M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
108.53K
High Today
$5.74
Low Today
$4.51
Open Price
$5.25
Volume
302.60K
52 Week High
$31.80
52 Week Low
$4.51

CUR Earnings

-$0.17
-$0.12
-$0.07
-$0.02
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Aug 13, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.